Abstract
The incidence of malignant melanoma has consistently increased since the beginning of the century: affecting i in 1,500 of the population in 1935 the incidence at the end of the 1980’s is approximately around 1/130 and will be 1/90 by the year 2,000. There is a great variation between different populations.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Balch CM, Cascinelli N, DrzewiecLi KT, et al (1992) A comparison of prognostic factors worldwide. In: CM Balch, AN Houghton, GW Milton, Sober, Soong (eds) Cutaneous Melanoma, 2nd edn. Lippincott, Philadelphia, pp 188–199
Buzaid AC, Sandler AB, Mani S, Mc Curtis A, Poo W, Bolognia JL, Ariyan S (1993) Role of computed tomography in the staging of primary melanoma. JCO 4: 638–643
Khansur T, Sanders J, Das SK (1989) Evaluation of staging work-up in malignant melanoma. Arch Surg 124: 847–849
Kirkwood JM, Myers JE, Vlock DR, et al (1982) Tomo-graphic gallium-67 citrate scanning: useful new surveillance for metastatic melanoma. Ann Intern Med 97: 694–699
Thomas JH, Panoussopoulous D, Liesmann GE,et al (1979) Scintiscans in the evaluation of patients with malignant melanomas. Surg Gynecol Obstet 149: 574–576
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1998 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Coeffic, D. et al. (1998). Malignant melanoma. In: Buthiau, D., Khayat, D. (eds) CT and MRI in Oncology. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-46842-1_40
Download citation
DOI: https://doi.org/10.1007/978-3-642-46842-1_40
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-46844-5
Online ISBN: 978-3-642-46842-1
eBook Packages: Springer Book Archive